Skip to content
All Brands

Fresenius Kabi Issues Nationwide

1 recall on record · Last recall: Aug 11, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
0
Class II — Moderate
0
Class III — Low Risk
0
Unclassified
1

Categories

MEDICATION

Recall Timeline

FDAAug 11, 2026

Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles

FOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to cont

Track Fresenius Kabi Issues Nationwide recalls automatically

Get an alert when a matching Fresenius Kabi Issues Nationwide recall turns up.

Start Free Trial